Kirsten R. Straasheijm
Nijmegen, GE 6525ED, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Human cortical spheroids with a high diversity of innately developing brain cell types.
Journal: Stem cell research & therapy
Published: June 03, 2022
Molecular Signature of Neuroinflammation Induced in Cytokine-Stimulated Human Cortical Spheroids.
Journal: Biomedicines
Published: March 24, 2022
Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies.
Journal: Journal of neuromuscular diseases
Published: May 24, 2021
Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.
Journal: Journal of medical genetics
Published: November 14, 2017
Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2.
Journal: European journal of human genetics : EJHG
Published: July 24, 2017
Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy.
Journal: American journal of human genetics
Published: November 24, 2015
Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.
Journal: Journal of neuroimmunology
Published: October 15, 2015
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 04, 2013
The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.
Journal: American journal of human genetics
Published: March 07, 2013
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2.
Journal: Nature genetics
Published: May 24, 2012
Last Updated: 09/26/2026